Search research articles
Contact Us
Filters
Showing results (31-40 of 40) with videos related to
Page
of 4
Sort By:
You have reached the last page of results.
This site can display upto 40 results.
Cancer Medicine
|
December 31, 2015
Postremission sequential monitoring of minimal residual disease by WT1 Q-PCR and multiparametric flow cytometry assessment predicts relapse and may help to address risk-adapted therapy in acute myeloid leukemia patients
Michele Malagola, Cristina Skert, Erika Borlenghi, et al.
Frontiers in Oncology
|
July 5, 2022
Results of an Innovative Program for Surveillance, Prophylaxis, and Treatment of Infectious Complications Following Allogeneic Stem Cell Transplantation in Hematological Malignancies (BATMO Protocol)
Michele Malagola, Alessandro Turra, Liana Signorini, et al.
Mediterranean Journal of Hematology and Infectious Diseases
|
July 13, 2017
Bacterial Blood Stream Infections Negatively Impact on Outcome of Patients Treated with Allogeneic Stem Cell Transplantation: 6 Years Single-Centre Experience
Michele Malagola, Bendetta Rambaldi, Giuseppe Ravizzola, et al.
Blood
|
March 12, 2010
Allogeneic transplantation improves the overall and progression-free survival of Hodgkin lymphoma patients relapsing after autologous transplantation: a retrospective study based on the time of HLA typing and donor availability
Barbara Sarina, Luca Castagna, Lucia Farina, et al.
Cell Biology International
|
March 1, 2025
Different In Vitro Models of Chronic Myeloid Leukemia Show Different Characteristics: Biological Replicates Are Not Biologically Equivalent
Alessia Cavalleri, Besjana Xhahysa, Silvia Mutti, et al.
Cancers
|
November 11, 2022
Timely Leukapheresis May Interfere with the "Fitness" of Lymphocytes Collected for CAR-T Treatment in High Risk DLBCL Patients
Mirko Farina, Marco Chiarini, Camillo Almici, et al.
Mediterranean Journal of Hematology and Infectious Diseases
|
September 19, 2019
CMV Management with Specific Immunoglobulins: A Multicentric Retrospective Analysis on 92 Allotransplanted Patients
Michele Malagola, Raffaella Greco, Stella Santarone, et al.
Bone Marrow Transplantation
|
June 24, 2026
A phase II multicenter prospective study to evaluate the safety and efficacy of myeloablative-dose treosulfan plus fludarabine (FT14) conditioning regimen in allogeneic hematopoietic stem cell transplantation for AML patients aged 40-65 in first complete remission
Daniele Avenoso, Vera Radici, Alessandro Leoni, et al.
Transplantation and Cellular Therapy
|
April 6, 2024
Evaluation of Circulating Endothelial Cells as Direct Marker of Endothelial Damage in Allo-Transplant Recipients at High Risk of Hepatic Veno-Occlusive Disease/Sinusoidal Obstruction Syndrome
Mirko Farina, Maria Chiara Scaini, Antonella Facchinetti, et al.
Blood Advances
|
February 10, 2025
Posttransplant cyclophosphamide as GVHD prophylaxis in patients receiving mismatched unrelated HCT: the PHYLOS trial
Anna Maria Raiola, Benedetto Bruno, Antonio Maria Risitano, et al.
Page
of 4
Search research articles
Search
Showing results (31-40 of 40) with videos related to
Sort By:
Page
of 4
You have reached the last page of results.
This site can display upto 40 results.
Cancer Medicine
|
December 31, 2015
Postremission sequential monitoring of minimal residual disease by WT1 Q-PCR and multiparametric flow cytometry assessment predicts relapse and may help to address risk-adapted therapy in acute myeloid leukemia patients
Michele Malagola, Cristina Skert, Erika Borlenghi, et al.
Frontiers in Oncology
|
July 5, 2022
Results of an Innovative Program for Surveillance, Prophylaxis, and Treatment of Infectious Complications Following Allogeneic Stem Cell Transplantation in Hematological Malignancies (BATMO Protocol)
Michele Malagola, Alessandro Turra, Liana Signorini, et al.
Mediterranean Journal of Hematology and Infectious Diseases
|
July 13, 2017
Bacterial Blood Stream Infections Negatively Impact on Outcome of Patients Treated with Allogeneic Stem Cell Transplantation: 6 Years Single-Centre Experience
Michele Malagola, Bendetta Rambaldi, Giuseppe Ravizzola, et al.
Blood
|
March 12, 2010
Allogeneic transplantation improves the overall and progression-free survival of Hodgkin lymphoma patients relapsing after autologous transplantation: a retrospective study based on the time of HLA typing and donor availability
Barbara Sarina, Luca Castagna, Lucia Farina, et al.
Cell Biology International
|
March 1, 2025
Different In Vitro Models of Chronic Myeloid Leukemia Show Different Characteristics: Biological Replicates Are Not Biologically Equivalent
Alessia Cavalleri, Besjana Xhahysa, Silvia Mutti, et al.
Cancers
|
November 11, 2022
Timely Leukapheresis May Interfere with the "Fitness" of Lymphocytes Collected for CAR-T Treatment in High Risk DLBCL Patients
Mirko Farina, Marco Chiarini, Camillo Almici, et al.
Mediterranean Journal of Hematology and Infectious Diseases
|
September 19, 2019
CMV Management with Specific Immunoglobulins: A Multicentric Retrospective Analysis on 92 Allotransplanted Patients
Michele Malagola, Raffaella Greco, Stella Santarone, et al.
Bone Marrow Transplantation
|
June 24, 2026
A phase II multicenter prospective study to evaluate the safety and efficacy of myeloablative-dose treosulfan plus fludarabine (FT14) conditioning regimen in allogeneic hematopoietic stem cell transplantation for AML patients aged 40-65 in first complete remission
Daniele Avenoso, Vera Radici, Alessandro Leoni, et al.
Transplantation and Cellular Therapy
|
April 6, 2024
Evaluation of Circulating Endothelial Cells as Direct Marker of Endothelial Damage in Allo-Transplant Recipients at High Risk of Hepatic Veno-Occlusive Disease/Sinusoidal Obstruction Syndrome
Mirko Farina, Maria Chiara Scaini, Antonella Facchinetti, et al.
Blood Advances
|
February 10, 2025
Posttransplant cyclophosphamide as GVHD prophylaxis in patients receiving mismatched unrelated HCT: the PHYLOS trial
Anna Maria Raiola, Benedetto Bruno, Antonio Maria Risitano, et al.
Page
of 4